Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion type Assertion NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_head.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is widely used by carriers of BRCA1 or BRCA2 (BRCA1/2) mutations to reduce their risks of breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_provenance.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion evidence source_evidence_literature NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_provenance.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion SIO_000772 19141781 NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_provenance.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion wasDerivedFrom befree-2016 NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_provenance.
- NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_assertion wasGeneratedBy ECO_0000203 NP713912.RAynuGWsuVO9JGpQasM5uGU-v2pGlFzTYCN3rfEUNkhSk130_provenance.